SEC Form 4 · accession 0001209191-19-003938
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Asaf Danziger
Officer — Chief Executive Officer · Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 16, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 14, 2019 | M | 100,000 | $3.44 | A | 271,164 | D | |
| Ordinary SharesF2 | Jan 14, 2019 | S | 100,000 | $43.524 | D | 171,164 | D | |
| Ordinary SharesF1 | Jan 15, 2019 | M | 100,000 | $3.44 | A | 271,164 | D | |
| Ordinary SharesF3 | Jan 15, 2019 | S | 100,000 | $43.488 | D | 171,164 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF4 | $3.44 | Jan 14, 2019 | M | 100,000 | D | — | Dec 13, 2021 | Ordinary Shares | 100,000 | 346,863 | D |
| Options to Buy Ordinary SharesF4 | $3.44 | Jan 15, 2019 | M | 100,000 | D | — | Dec 13, 2021 | Ordinary Shares | 100,000 | 246,863 | D |
Explanation of responses
- F1These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.
- F2On January 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.66. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3On January 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.92. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F4Fully vested and currently exercisable as of the date hereof.